Inhibitory Antibodies
-
F1492 Anti-CLDN18.2 Antibody (Zolbetuximab)Summary: Anti-CLDN18.2 Antibody (Zolbetuximab) -
F1493 Anti-ILDR2 Antibody (Bapotulimab)Summary: Anti-ILDR2 Antibody (Bapotulimab) -
F1494 Anti-CD44v6 Antibody (Bivatuzumab)Summary: Anti-CD44v6 Antibody (Bivatuzumab) -
F1495 Anti-IGF1R/CD221 Antibody (Cixutumumab)Summary: Anti-IGF1R/CD221 Antibody (Cixutumumab) -
F1496 Anti-GPC3/Glypican-3 Antibody (Codrituzumab)Summary: Anti-GPC3/Glypican-3 Antibody (Codrituzumab) -
F1497 Anti-ICOS/CD278 Antibody (Feladilimab)Summary: Anti-ICOS/CD278 Antibody (Feladilimab) -
F1498 Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab)Summary: Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab) -
F1499 Anti-GDF8/Myostatin Antibody (Landogrozumab)Summary: Anti-GDF8/Myostatin Antibody (Landogrozumab) -
F1500 Anti-AMHR2 Antibody (Murlentamab)Summary: Anti-AMHR2 Antibody (Murlentamab) -
F1501 Anti-GD2 Antibody (Naxitamab)Summary: Anti-GD2 Antibody (Naxitamab)